We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Zota Pharmaceuticals has recently upgraded its manufacturing facility and received approval from Nigerian authorities to export products to Nigeria, reports the Indian pharmaceutical news source Pharmabiz.
U.S. drug companies will increasingly outsource their clinical trials in the coming years, with "many top pharmaceutical companies" expecting to do up to 65 percent of their clinical trials abroad, according to the "Outlook 2007" survey by the Tufts Center for the Study of Drug Development.
Eisai, which along with Pfizer markets Aricept (donepezil hydrochloride), announced Friday that it has formally submitted an application to the UK High Court requesting a judicial review of the process by which the National Institute for Health and Clinical Excellence (NICE) decided against allowing Aricept to be prescribed to treat newly diagnosed, mild Alzheimer's disease.
The Global AIDS Alliance has decried U.S. Congress' expected decision to cut 2007 funding for programs to fight HIV, tuberculosis (TB) and malaria in Africa.
BioCryst Pharmaceuticals announced it has been awarded a four-year, $102.6 million contract from the U.S. HHS to develop its influenza neuraminidase inhibitor, peramivir, for the treatment of seasonal and pandemic influenza, including avian flu.
Swiss drugmaker Roche has announced a new partnership with Synosis Therapeutics to develop treatments for schizophrenia, cognitive disorders, Parkinson's disease, drug dependency and pain.